These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15579068)

  • 21. An RNA domain within the 5' untranslated region of the tomato bushy stunt virus genome modulates viral RNA replication.
    Wu B; Vanti WB; White KA
    J Mol Biol; 2001 Jan; 305(4):741-56. PubMed ID: 11162089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells.
    Lerat H; Shimizu YK; Lemon SM
    J Virol; 2000 Aug; 74(15):7024-31. PubMed ID: 10888641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
    Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
    J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the 5'-proximal stem-loop structure of the 5' untranslated region in replication and translation of hepatitis C virus RNA.
    Luo G; Xin S; Cai Z
    J Virol; 2003 Mar; 77(5):3312-8. PubMed ID: 12584356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C viral RNA: challenges and promises.
    Shi ST; Lai MM
    Cell Mol Life Sci; 2001 Aug; 58(9):1276-95. PubMed ID: 11577984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the hepatitis C virus genome replication by miR-199a.
    Murakami Y; Aly HH; Tajima A; Inoue I; Shimotohno K
    J Hepatol; 2009 Mar; 50(3):453-60. PubMed ID: 19144437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication.
    Romero-López C; Berzal-Herranz B; Gómez J; Berzal-Herranz A
    Antiviral Res; 2012 May; 94(2):131-8. PubMed ID: 22426470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome.
    Beerens N; Klaver B; Berkhout B
    J Virol; 2000 Mar; 74(5):2227-38. PubMed ID: 10666253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
    Ikeda M; Yi M; Li K; Lemon SM
    J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C.
    Motavaf M; Safari S; Alavian SM
    J Viral Hepat; 2012 Nov; 19(11):757-65. PubMed ID: 23043382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
    Romero-López C; Lahlali T; Berzal-Herranz B; Berzal-Herranz A
    Molecules; 2017 May; 22(5):. PubMed ID: 28531161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Structure and function of the non-coding regions of hepatitis C viral RNA].
    Dutkiewicz M; Swiqtkowska A; Ciesiołka J
    Postepy Biochem; 2006; 52(1):62-71. PubMed ID: 16869303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Replication of hepatitis C virus genome].
    Kato N
    Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IRES complexity before IFN-alpha treatment and evolution of the viral load at the early stage of treatment in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Thélu MA; Leroy V; Ramzan M; Dufeu-Duchesne T; Marche P; Zarski JP
    J Med Virol; 2007 Mar; 79(3):242-53. PubMed ID: 17245718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.
    Macejak DG; Jensen KL; Jamison SF; Domenico K; Roberts EC; Chaudhary N; von Carlowitz I; Bellon L; Tong MJ; Conrad A; Pavco PA; Blatt LM
    Hepatology; 2000 Mar; 31(3):769-76. PubMed ID: 10706571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication.
    Tanaka T; Otoguro T; Yamashita A; Kasai H; Fukuhara T; Matsuura Y; Moriishi K
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Structure and function of HAV genome (RNA)].
    Shimoike T
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():428-32. PubMed ID: 15453360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.